Terveystalo Oyj provides healthcare services in Finland.
Reasonable growth potential with mediocre balance sheet.
Share Price & News
How has Terveystalo Oyj's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: TTALO has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: TTALO underperformed the Finnish Healthcare industry which returned 3.7% over the past year.
Return vs Market: TTALO underperformed the Finnish Market which returned 4.6% over the past year.
Price Volatility Vs. Market
How volatile is Terveystalo Oyj's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StShould Terveystalo Oyj (HEL:TTALO) Be Part Of Your Dividend Portfolio?
3 weeks ago | Simply Wall StEarnings Miss: Terveystalo Oyj Missed EPS By 6.7% And Analysts Are Revising Their Forecasts
1 month ago | Simply Wall StDon't Sell Terveystalo Oyj (HEL:TTALO) Before You Read This
Is Terveystalo Oyj undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: TTALO (€9.41) is trading below our estimate of fair value (€12.15)
Significantly Below Fair Value: TTALO is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: TTALO is poor value based on its PE Ratio (26.3x) compared to the Healthcare industry average (21.7x).
PE vs Market: TTALO is poor value based on its PE Ratio (26.3x) compared to the Finnish market (19.8x).
Price to Earnings Growth Ratio
PEG Ratio: TTALO is poor value based on its PEG Ratio (1.1x)
Price to Book Ratio
PB vs Industry: TTALO is overvalued based on its PB Ratio (2.1x) compared to the XE Healthcare industry average (1.8x).
How is Terveystalo Oyj forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TTALO's forecast earnings growth (23.5% per year) is above the savings rate (0.4%).
Earnings vs Market: TTALO's earnings (23.5% per year) are forecast to grow faster than the Finnish market (14.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: TTALO's revenue (6.1% per year) is forecast to grow faster than the Finnish market (5.9% per year).
High Growth Revenue: TTALO's revenue (6.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TTALO's Return on Equity is forecast to be low in 3 years time (12%).
How has Terveystalo Oyj performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TTALO has high quality earnings.
Growing Profit Margin: TTALO's current net profit margins (4.5%) are lower than last year (7.2%).
Past Earnings Growth Analysis
Earnings Trend: TTALO has become profitable over the past 5 years, growing earnings by 44.2% per year.
Accelerating Growth: TTALO's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: TTALO had negative earnings growth (-21.9%) over the past year, making it difficult to compare to the Healthcare industry average (-2%).
Return on Equity
High ROE: TTALO's Return on Equity (8.3%) is considered low.
How is Terveystalo Oyj's financial position?
Financial Position Analysis
Short Term Liabilities: TTALO's short term assets (€158.2M) do not cover its short term liabilities (€267.2M).
Long Term Liabilities: TTALO's short term assets (€158.2M) do not cover its long term liabilities (€543.8M).
Debt to Equity History and Analysis
Debt Level: TTALO's debt to equity ratio (70.8%) is considered high.
Reducing Debt: TTALO's debt to equity ratio has reduced from 135.5% to 70.8% over the past 5 years.
Debt Coverage: TTALO's debt is well covered by operating cash flow (40.4%).
Interest Coverage: TTALO's interest payments on its debt are well covered by EBIT (6.6x coverage).
What is Terveystalo Oyj's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: TTALO's dividend (1.38%) isn’t notable compared to the bottom 25% of dividend payers in the Finnish market (2.44%).
High Dividend: TTALO's dividend (1.38%) is low compared to the top 25% of dividend payers in the Finnish market (5.03%).
Stability and Growth of Payments
Stable Dividend: TTALO is not paying a notable dividend for the Finnish market, therefore no need to check if payments are stable.
Growing Dividend: TTALO is not paying a notable dividend for the Finnish market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: TTALO is not paying a notable dividend for the Finnish market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of TTALO's dividend in 3 years as they are not forecast to pay a notable one for the Finnish market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ville Iho (50yo)
Mr. Ville Iho has been President & CEO of Terveystalo Oyj since December 6, 2019. Mr. Iho served as Chief Executive Officer at Nurminen Logistics Oyj since March 18, 2019 until December 05, 2019 and its Pr ...
CEO Compensation Analysis
Compensation vs Market: Ville's total compensation ($USD30.35K) is below average for companies of similar size in the Finnish market ($USD1.71M).
Compensation vs Earnings: Insufficient data to compare Ville's compensation with company performance.
|President & CEO||0.50yr||€27.27k||no data|
|Chief Financial Officer||5.42yrs||no data||0.25% €3.0m|
|Director of Investor Relations & Financial Communications||no data||no data||no data|
|Senior VP of Marketing & Communications||0.083yr||no data||no data|
|Senior Vice President of Human Resources||0.33yr||no data||no data|
|Chief Digital Officer||4.42yrs||no data||0.070% €832.7k|
|Senior Vice President of Public Partnerships||4.42yrs||no data||no data|
|Senior Vice President of Private Customers & Clinics||4.42yrs||no data||0.040% €475.7k|
|Senior Vice President of Well-being||4.42yrs||no data||0.019% €222.0k|
|Chief Medical Officer||1.33yrs||no data||no data|
Experienced Management: TTALO's management team is considered experienced (4.4 years average tenure).
|Independent Director||4.42yrs||€63.25k||0.020% €242.3k|
|Independent Chairman of the Board||1.17yrs||€91.31k||0.0033% €40.0k|
|Independent Director||no data||€61.91k||0.0086% €102.9k|
|Independent Director||1.17yrs||€50.05k||0.0013% €15.9k|
|Independent Vice-Chairman of the Board||2.17yrs||€61.91k||0.0031% €37.0k|
|Independent Director||0.083yr||no data||no data|
|Independent Director||2.17yrs||€53.65k||0.0025% €29.5k|
Experienced Board: TTALO's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Terveystalo Oyj's company bio, employee growth, exchange listings and data sources
- Name: Terveystalo Oyj
- Ticker: TTALO
- Exchange: HLSE
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: €1.198b
- Shares outstanding: 127.31m
- Website: https://www.terveystalo.com
Number of Employees
- Terveystalo Oyj
- Jaakonkatu 3 B
- 3rd Floor
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|TTALO||HLSE (OMX Nordic Exchange Helsinki)||Yes||Common Shares||FI||EUR||Oct 2017|
|4TS||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Oct 2017|
|0RV1||LSE (London Stock Exchange)||Yes||Common Shares||GB||EUR||Oct 2017|
|TTAL.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Oct 2017|
|TTALOH||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Common Shares||GB||EUR||Oct 2017|
Terveystalo Oyj provides healthcare services in Finland. The company offers versatile and occupational healthcare, medical and examination, diagnostic, outpatient surgery, dental, and other services; and laboratory, imaging, wellbeing, day surgery, healthcare outsourcing, healthcare staffing, and primary and specialty care services. It also provides a suite of digital healthcare services; and insurance and clinical research services. The company serves private individuals, companies and communities, insurance companies, and public sector customers. The company operates through approximately 300 clinics, including 17 clinic-hospitals, 40 dental clinics, and 170 physiotherapy clinics, as well as 47 clinics with imaging services. The company was founded in 2001 and is based in Helsinki, Finland.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/06/02 11:29|
|End of Day Share Price||2020/06/01 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.